Avi Salzman — Holtec Just Scrapped Its IPO—But Don't Burn Out on Nuclear Stocks Yet

X-Energy designs a new kind of smaller nuclear reactor and has been signing commercial agreements with customers who want to buy them. The article counts it as one of the upstarts "making steady progress" — and when Holtec, a much larger nuclear company, abandoned its plan to sell shares to the public, X-Energy's stock jumped 12% in a day.

The logic of that jump: investors who want to own nuclear power have a limited pool of money for it. A $900 million Holtec listing would have competed for that money; with it gone, the existing listed names are the only way in. The catch the article states plainly is timing — these reactors won't be switched on for years and still have to get through the nuclear regulator, so the stock is a bet on contracts turning into working plants a long way out.

Oklo is another start-up reactor developer, paired in the article with X-Energy: both have been signing deals for new reactors, and both rose 12% the day Holtec pulled out of the stock market. It is the same "less competition for investor money" reaction.

The same warning applies too. Signed deals are not operating reactors; Oklo's are years away and still need regulatory approval. The article's bigger point — don't abandon the nuclear industry because one IPO failed — is supportive, but the one-day rally reflects relief, not new evidence that the reactors will work on time or on budget.

Holtec is a New Jersey nuclear company with an unusual mix of businesses: it gets paid to take apart old nuclear plants, it sells the heavy containers ("casks") used to store spent nuclear fuel, it is developing small reactors, and it is about to restart a shut-down reactor in Michigan called Palisades. It was about to sell shares to the public — roughly $900 million worth at a $10 billion company value — and then canceled late Wednesday, blaming market conditions.

Two things went wrong. First, nuclear stocks have cooled a lot this year, so the price it could get was lower than it would have been a year ago. Second, the share structure: the founder-CEO, Kris Singh, would have kept majority voting control through a special class of shares ordinary investors couldn't buy, and shareholders would have had no way to remove him or his wife, who is vice chair. In a hot market investors tolerate that; in a cold one they push back, and some did.

It stays Neutral because nothing here says the business is bad — the decommissioning and cask lines are real, steady work — but the reactor-building part is, in the article's words, its riskiest gamble in a crowded field. If it tries to list again, the terms (especially voting control) are the thing to check.

BWXT builds nuclear reactors and fuel for the U.S. Navy and is the listed company investors compare Holtec to. Here it is used as a thermometer, not a recommendation: it is down 19% this year, which is part of why Holtec could not get the price it wanted.

Note the day's moves: BWXT rose half a percent while the start-ups rose 12%. The start-ups benefit most from a rival listing disappearing; an established contractor with real revenue is priced on its own orders, not on the flow of investor money into the theme.

NLR is a fund that holds a basket of uranium miners, utilities with nuclear plants and nuclear-equipment companies — a one-ticket way to own the whole sector. It is down 13% this year, and the article uses that as the measure of how much the nuclear excitement of the past two years has faded. A falling sector fund is exactly the "market conditions" that made Holtec cancel.